Friedrich-Baur-Institute, Dept. of Neurology, Ludwig-Maximilians-University of Munich

Flag of

  004989440057400  |     baur-institut.de  |    fbi@med.lmu.de

The Friedrich-Baur-Insitute is the largest neuromuscular centre in Germany with about 1000 in-patients and 3000 out-patients per year (solely with neuromuscular diseaes), providing integrated clinical services for neuromuscular patients including clinical assessment, electrophysiology, muscle and nerve pathology, immunhistochemistry and immunoblotting, muscle biochemistry, muscle and nerve ultrasound, whole-body muscle MRI, genetic services, physiotherapy, rehabilitation therapy, counselling and social services. Moreover, the Friedrich-Baur-Institute is among the most research-active institutions for neuromuscular disorders in Europe with more than 350 research publications and a grant income exceeding 5 Mio. € in the last 5 years including several completed and ongoing clincial trials (www.baur-institut.de).

In an interdisciplinary approach, we bring together experts from different areas of research to collaborate on the epidemiology, diagnosis, molecular pathogenesis and treatment of muscular dystrophy, comprising participants from Neurology, Paediatric Neurology, Neuropathology, Human Genetics, Internal Medicine, Physiology, Developmental Biology, Molecular Pathology, Cell Biology, and Biochemistry.

Our experts are working in assessing new therapeutics and animal models, and in developing standard protocols for diagnosis, and standards of care in neuromuscular diseases. We lead activities on harmonized European patient databases, biobanks and clinical trials, ensuring “trial readiness”. Additionally, we educate a new generation of specifically trained researchers and clinicians as ‘Myologists’. Additionally, we implement and disseminate results to professionals, patient organizations and the wider public, and collaborate with other partners and networks of rare disorders.

The ultimate goal is providing better diagnosis, treatment and care for all NMD patients in Germany.

Board representation

Prof Dr Maggie C. Walter M.A.

Maggie C. Walter is Associate Professor of Neurology at the Ludwig-Maximilians-University of Munich. She has trained as a neurologist at the LMU Munich, and is working at the Friedrich-Baur-Institute, the neuromuscular department of the LMU, in leading position. Furthermore, she graduated with a master degree in management of social and health institutions. Her main research interests are neuromuscular diseases, mainly …

Location

Group membership

Friedrich-Baur-Institute, Dept. of Neurology, Ludwig-Maximilians-University of Munich participates in the following groups…

Specialised Groups

Muscle diseases
Peripheral Nerve Disease
Motor Neuron Disease
Neuromuscular Junction Defects
Mitochondrial Diseases

Cross Cutting Specialised Groups

Neuromuscular Imaging
Neurophysiology
Neuropathology
Genetics

Advisory Boards

Research
Friedrich-Baur-Institute, Dept. of Neurology, Ludwig-Maximilians-University of Munich is registered with the Care and Trial Site Registry

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern